Format
Items per page
Sort by

Send to:

Choose Destination

Search results

Items: 1 to 20 of 211

1.

Validation of a standardized extraction method for formalin-fixed paraffin-embedded tissue samples.

Lagheden C, Eklund C, Kleppe SN, Unger ER, Dillner J, Sundström K.

J Clin Virol. 2016 Apr 27;80:36-39. doi: 10.1016/j.jcv.2016.04.016. [Epub ahead of print]

PMID:
27148635
2.

Methods of applying the 1994 case definition of chronic fatigue syndrome - impact on classification and observed illness characteristics.

Unger ER, Lin JM, Tian H, Gurbaxani BM, Boneva RS, Jones JF.

Popul Health Metr. 2016 Mar 12;14:5. doi: 10.1186/s12963-016-0077-1. eCollection 2016.

3.

Prevalence of HPV After Introduction of the Vaccination Program in the United States.

Markowitz LE, Liu G, Hariri S, Steinau M, Dunne EF, Unger ER.

Pediatrics. 2016 Mar;137(3):1-9. doi: 10.1542/peds.2015-1968. Epub 2016 Feb 22.

PMID:
26908697
4.

Response to Pendleton et al. regarding reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States.

Hariri S, Markowitz LE, Unger ER.

Vaccine. 2016 Jan 4;34(2):201. doi: 10.1016/j.vaccine.2015.10.138. Epub 2015 Dec 2. No abstract available.

PMID:
26655631
5.

Human papillomavirus genotype and oropharynx cancer survival in the United States of America.

Goodman MT, Saraiya M, Thompson TD, Steinau M, Hernandez BY, Lynch CF, Lyu CW, Wilkinson EJ, Tucker T, Copeland G, Peters ES, Altekruse S, Unger ER.

Eur J Cancer. 2015 Dec;51(18):2759-67. doi: 10.1016/j.ejca.2015.09.005. Epub 2015 Nov 18.

PMID:
26602016
6.

Seroprevalence of 9 Human Papillomavirus Types in the United States, 2005-2006.

Liu G, Markowitz LE, Hariri S, Panicker G, Unger ER.

J Infect Dis. 2016 Jan 15;213(2):191-8. doi: 10.1093/infdis/jiv403. Epub 2015 Aug 27.

PMID:
26320259
7.

Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008-2012.

Hariri S, Markowitz LE, Bennett NM, Niccolai LM, Schafer S, Bloch K, Park IU, Scahill MW, Julian P, Abdullah N, Levine D, Whitney E, Unger ER, Steinau M, Bauer HM, Meek J, Hadler J, Sosa L, Powell SE, Johnson ML; Hpv-Impact Working Group.

Emerg Infect Dis. 2015 Sep;21(9):1557-61. doi: 10.3201/eid2109.141841.

8.

Incidence and Predictors of Abnormal Anal Cytology Findings Among HIV-Infected Adults Receiving Contemporary Antiretroviral Therapy.

Conley LJ, Bush TJ, Darragh TM, Palefsky JM, Unger ER, Patel P, Steinau M, Kojic EM, Martin H, Overton ET, Cu-Uvin S, Hammer J, Henry K, Wood K, Brooks JT; SUN Study Group.

J Infect Dis. 2016 Feb 1;213(3):351-60. doi: 10.1093/infdis/jiv408. Epub 2015 Aug 12.

PMID:
26268855
9.

Reduction in Human Papillomavirus Vaccine Type Prevalence Among Young Women Screened for Cervical Cancer in an Integrated US Healthcare Delivery System in 2007 and 2012-2013.

Dunne EF, Naleway A, Smith N, Crane B, Weinmann S, Braxton J, Steinau M, Unger ER, Markowitz LE.

J Infect Dis. 2015 Dec 15;212(12):1970-5. doi: 10.1093/infdis/jiv342. Epub 2015 Jun 29.

PMID:
26123561
10.

Pathway-focused genetic evaluation of immune and inflammation related genes with chronic fatigue syndrome.

Rajeevan MS, Dimulescu I, Murray J, Falkenberg VR, Unger ER.

Hum Immunol. 2015 Aug;76(8):553-60. doi: 10.1016/j.humimm.2015.06.014. Epub 2015 Jun 24.

11.

Population-based trends in high-grade cervical lesions in the early human papillomavirus vaccine era in the United States.

Hariri S, Johnson ML, Bennett NM, Bauer HM, Park IU, Schafer S, Niccolai LM, Unger ER, Markowitz LE; HPV-IMPACT Working Group.

Cancer. 2015 Aug 15;121(16):2775-81. doi: 10.1002/cncr.29266. Epub 2015 Jun 22.

PMID:
26098295
12.

US assessment of HPV types in cancers: implications for current and 9-valent HPV vaccines.

Saraiya M, Unger ER, Thompson TD, Lynch CF, Hernandez BY, Lyu CW, Steinau M, Watson M, Wilkinson EJ, Hopenhayn C, Copeland G, Cozen W, Peters ES, Huang Y, Saber MS, Altekruse S, Goodman MT; HPV Typing of Cancers Workgroup.

J Natl Cancer Inst. 2015 Apr 29;107(6):djv086. doi: 10.1093/jnci/djv086. Print 2015 Jun.

PMID:
25925419
13.

Use of 9-valent human papillomavirus (HPV) vaccine: updated HPV vaccination recommendations of the advisory committee on immunization practices.

Petrosky E, Bocchini JA Jr, Hariri S, Chesson H, Curtis CR, Saraiya M, Unger ER, Markowitz LE; Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 2015 Mar 27;64(11):300-4.

14.

Oral human papillomavirus is common in individuals with Fanconi anemia.

Sauter SL, Wells SI, Zhang X, Hoskins EE, Davies SM, Myers KC, Mueller R, Panicker G, Unger ER, Sivaprasad U, Brown DR, Mehta PA, Butsch Kovacic M.

Cancer Epidemiol Biomarkers Prev. 2015 May;24(5):864-72. doi: 10.1158/1055-9965.EPI-15-0097-T. Epub 2015 Mar 25.

15.

Antibody responses among adolescent females receiving the quadrivalent HPV vaccine series corresponding to standard or non-standard dosing intervals.

Russell K, Dunne EF, Kemper AR, Dolor RJ, Unger ER, Panicker G, Markowitz LE, Walter EB.

Vaccine. 2015 Apr 15;33(16):1953-8. doi: 10.1016/j.vaccine.2015.02.058. Epub 2015 Mar 3.

PMID:
25744229
16.

Reduction in HPV 16/18-associated high grade cervical lesions following HPV vaccine introduction in the United States - 2008-2012.

Hariri S, Bennett NM, Niccolai LM, Schafer S, Park IU, Bloch KC, Unger ER, Whitney E, Julian P, Scahill MW, Abdullah N, Levine D, Johnson ML, Steinau M, Markowitz LE; HPV-IMPACT Working Group.

Vaccine. 2015 Mar 24;33(13):1608-13. doi: 10.1016/j.vaccine.2015.01.084. Epub 2015 Feb 11.

PMID:
25681664
17.

Early menopause and other gynecologic risk indicators for chronic fatigue syndrome in women.

Boneva RS, Lin JM, Unger ER.

Menopause. 2015 Aug;22(8):826-34. doi: 10.1097/GME.0000000000000411.

PMID:
25647777
18.

Is vaccine type seropositivity a marker for human papillomavirus vaccination? National Health and Nutrition Examination Survey, 2003-2010.

Petrosky EY, Hariri S, Markowitz LE, Panicker G, Unger ER, Dunne EF.

Int J Infect Dis. 2015 Apr;33:137-41. doi: 10.1016/j.ijid.2015.01.010. Epub 2015 Jan 14.

19.

Development and evaluation of multiplexed immunoassay for detection of antibodies to HPV vaccine types.

Panicker G, Rajbhandari I, Gurbaxani BM, Querec TD, Unger ER.

J Immunol Methods. 2015 Feb;417:107-14. doi: 10.1016/j.jim.2014.12.013. Epub 2014 Dec 30.

20.

Human papillomavirus prevalence in invasive laryngeal cancer in the United States.

Hernandez BY, Goodman MT, Lynch CF, Cozen W, Unger ER, Steinau M, Thompson T, Saber MS, Altekruse SF, Lyu C, Saraiya M; HPV Typing of Cancer Workgroup.

PLoS One. 2014 Dec 29;9(12):e115931. doi: 10.1371/journal.pone.0115931. eCollection 2014.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk